The increase in new and more targeted therapies for chronic dermatology conditions, such as psoriasis and atopic dermatitis, has been underway for a few years thanks to rise in innovative biologics. However, achieving ideal enrollment rates remains a challenge and requires a thoughtful site strategy. In this podcast, our speakers will address considerations to improve success of dermatology trials.
Dr. Michael Noss
Senior Director of U.S. Medical Operations, Principal Investigator, Synexus
Sr. Director of Project Management, PPD
Dr. Vanessa Elharrar
Regional Medical Officer, PPD Biotech
Listen to the podcast below
Contact PPD Biotech
We are ready to partner with you to drive your innovative new therapies forward
To contact us about our dermatology capabilities, please complete the form. Fields marked with * are required.